These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6028842)

  • 1. Experimental arterial thrombus prevention and renal function in sheep after infusion with low molecular weight dextran and dextran 70,000.
    Hunt PS; Reeve TS
    Ann Surg; 1967 Jul; 166(1):51-8. PubMed ID: 6028842
    [No Abstract]   [Full Text] [Related]  

  • 2. Recurrence of experimental thrombus after thrombectomy: effects of heparin and rheomacrodex.
    Hunt PS; Reeve TS
    Aust N Z J Surg; 1968 May; 37(4):401-2. PubMed ID: 5243177
    [No Abstract]   [Full Text] [Related]  

  • 3. Arterial thrombus prevention and dissolution after low molecular weight dextran infusion in sheep.
    Hunt PS; Reeve TS
    Med J Aust; 1967 Mar; 1(11):539-41. PubMed ID: 6023810
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevention and therapy of thromboembolic complications with dextran.
    Bygdeman S
    Prog Surg; 1969; 7():114-39. PubMed ID: 4891952
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of low-molecular-weight dextran on postoperative renal function.
    Matheson NA; Harper DR; Hedley AJ; Irvin TT
    Lancet; 1965 Apr; 1(7389):779-81. PubMed ID: 4165082
    [No Abstract]   [Full Text] [Related]  

  • 6. INFLUENCE OF MANNITOL AND LOW MOLECULAR WEIGHT DEXTRAN UPON RENAL BLOOD FLOW.
    JUDD D; HERENDEEN T; SHUMACKER HB
    Surgery; 1964 Sep; 56():529-32. PubMed ID: 14215711
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect and clinical significance of low molecular weight and clinical dextran on an experimental venous thrombus in sheep.
    Johnson DC; Reeve TS
    Ann Surg; 1968 Jul; 168(1):123-7. PubMed ID: 5673188
    [No Abstract]   [Full Text] [Related]  

  • 8. [Summary of a workshop at the Reinenburg, Ulm, on thrombosis prevention with Dextran].
    Hey D
    Infusionstherapie (1973); 1973 Dec; 1(2):174. PubMed ID: 4805900
    [No Abstract]   [Full Text] [Related]  

  • 9. Intra-arterial infusion of dextran. A new concept to prevent sludging and thrombosis in vascular surgery.
    Fadhli HA; Fine DP; Mazuji MK
    J Thorac Cardiovasc Surg; 1967 Apr; 53(4):496-9. PubMed ID: 6022403
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prevention of thrombosis with coumarin, low doses of heparin, dextran and inhibitors of platelet function].
    Loeliger EA
    Ned Tijdschr Geneeskd; 1977 Oct; 121(44):1748-54. PubMed ID: 335258
    [No Abstract]   [Full Text] [Related]  

  • 11. [Diagnosis of thrombosis with radioactively marked fibrinogen. A comparison of thrombosis prevention using Dextran and heparin].
    Myrvold H; Svensson B; Wallensten S; Vikterlöf KJ
    Nord Med; 1971 Dec; 86(51):1584-5. PubMed ID: 5134772
    [No Abstract]   [Full Text] [Related]  

  • 12. Proceedings: A randomized comparative study on early prophylactic treatment of thrombosis using heparin and high-molecular dextran following injuries of the lower-leg.
    Gaudernak T; Kuderna H; Olbert F; Pelinka H; Schlag G
    Thromb Diath Haemorrh; 1975 Nov; 34(2):597. PubMed ID: 1198515
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of low molecular weight heparin, dextran and their combinations on experimental venous thrombosis in rabbits.
    Matthiasson SE; Lindblad B; Mätzsch T; Holst J; Bergqvist D
    Thromb Haemost; 1994 Mar; 71(3):363-5. PubMed ID: 7518099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin versus dextran in the prevention of deep-vein thrombosis. A multi-unit coctrolled trial.
    Lancet; 1974 Jul; 2(7873):118-20. PubMed ID: 4135556
    [No Abstract]   [Full Text] [Related]  

  • 15. DEXTRAN THERAPY IN THROMBOPHLEBITIS.
    SAWYER RB; MONCRIEF JA; CANIZARO PC
    JAMA; 1965 Mar; 191():740-2. PubMed ID: 14245515
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of heparin, plasmin, dextran, and low molecular dextran on bioelectrically induced thromboses.
    Flemma RJ; Silver D; Anlyan WG
    Surg Forum; 1965; 16():123-4. PubMed ID: 4220793
    [No Abstract]   [Full Text] [Related]  

  • 17. [PROLONGED INTRA-ARTERIAL INFUSIONS WITH VASODILATORS AND LOW-MOLECULAR WEIGHT DEXTRAN IN THE TREATMENT OF PERIPHERAL ARTERIAL CIRCULATION DISORDERS].
    MARTI WK
    Schweiz Med Wochenschr; 1963 Dec; 93():1746-9. PubMed ID: 14098621
    [No Abstract]   [Full Text] [Related]  

  • 18. [Oral anticoagulants, dextran or low-dose subcutaneous heparin: which is it to be in the prophylaxis of deep vein thrombosis of operated patients? (author's transl)].
    Verstraete M
    Przegl Lek; 1977; 34(10):777-9. PubMed ID: 594414
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevention of postoperative thromboembolism by dextran 70 or low-dose heparin.
    Hohl MK; Lüscher KP; Tichý J; Stiner M; Fridrich R; Gruber UF; Käser O
    Obstet Gynecol; 1980 Apr; 55(4):497-500. PubMed ID: 6154272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevention of postoperative thrombosis with low molecular weight dextran. Apropos of a series using a radioactive isotope technic].
    Houel F; Farhathaidar A; Rasolomala R; Mercier C
    Anesth Analg (Paris); 1976; 3(4):593-6. PubMed ID: 1015646
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.